Harbin Pharmaceutical Group Co (SHSE:600664) Cyclically Adjusted Book per Share: ¥2.22 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600664 Harbin Pharmaceutical Group Co Ltd SHSE:600664
66 GF Score
Price ¥4.94
GF Value ¥3.51
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Harbin Pharmaceutical Group Co Cyclically Adjusted Book per Share?

Harbin Pharmaceutical Group Co SHSE:600664 +10.02% 66 Cyclically Adjusted Book per Share is ¥2.22 as of Mar. 2026. GuruFocus rates SHSE:600664 with a GF Score™ of 66/100 and a GF Value™ of ¥3.51 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Harbin Pharmaceutical Group Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥2.327. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥2.22 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Harbin Pharmaceutical Group Co's average Cyclically Adjusted Book Growth Rate was -3.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -6.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -6.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Harbin Pharmaceutical Group Co was 14.00% per year. The lowest was -6.90% per year. And the median was 1.95% per year.

As of today (2026-07-16), Harbin Pharmaceutical Group Co's current stock price is ¥4.94. Harbin Pharmaceutical Group Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥2.22. Harbin Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is 2.23.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Harbin Pharmaceutical Group Co was 2.95. The lowest was 0.77. And the median was 1.25.


Harbin Pharmaceutical Group Co  (SHSE:600664) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Harbin Pharmaceutical Group Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.94/2.22
=2.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Harbin Pharmaceutical Group Co was 2.95. The lowest was 0.77. And the median was 1.25.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Harbin Pharmaceutical Group Co Cyclically Adjusted Book per Share Related Terms


Harbin Pharmaceutical Group Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Harbin Pharmaceutical Group Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harbin Pharmaceutical Group Co Cyclically Adjusted Book per Share Chart

Harbin Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.91 2.75 2.53 2.35 2.24

Harbin Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.31 2.27 2.26 2.24 2.22

SHSE:600664 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Pharmaceutical Group Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600664
66GF Score
Harbin Pharmaceutical Group Co Ltd SHSE:600664
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harbin Pharmaceutical Group Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Harbin Pharmaceutical Group Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.327/116.3033*116.3033
=2.327

Current CPI (Mar. 2026) = 116.3033.

Harbin Pharmaceutical Group Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.981 101.400 3.419
201609 3.016 102.400 3.425
201612 3.090 102.600 3.503
201703 2.608 103.200 2.939
201706 2.727 103.100 3.076
201709 2.684 104.100 2.999
201712 2.765 104.500 3.077
201803 2.827 105.300 3.122
201806 2.415 104.900 2.678
201809 2.370 106.600 2.586
201812 2.305 106.500 2.517
201903 2.062 107.700 2.227
201906 1.951 107.700 2.107
201909 2.079 109.800 2.202
201912 2.177 111.200 2.277
202003 2.040 112.300 2.113
202006 1.760 110.400 1.854
202009 1.670 111.700 1.739
202012 1.388 111.500 1.448
202103 1.415 112.662 1.461
202106 1.502 111.769 1.563
202109 1.559 112.215 1.616
202112 1.528 113.108 1.571
202203 1.566 114.335 1.593
202206 1.580 114.558 1.604
202209 1.593 115.339 1.606
202212 1.713 115.116 1.731
202303 1.765 115.116 1.783
202306 1.789 114.558 1.816
202309 1.834 115.339 1.849
202312 1.874 114.781 1.899
202403 1.944 115.227 1.962
202406 2.001 114.781 2.028
202409 2.069 115.785 2.078
202412 2.124 114.893 2.150
202503 2.209 115.116 2.232
202506 2.227 114.907 2.254
202509 2.247 115.471 2.263
202512 2.259 115.832 2.268
202603 2.327 116.303 2.327

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥2.22 mean?
Harbin Pharmaceutical Group Co (SHSE:600664) has a Cyclically Adjusted Book per Share of ¥2.22 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Harbin Pharmaceutical Group Co and its competitors.
Is Harbin Pharmaceutical Group Co's Cyclically Adjusted Book per Share too high?
Harbin Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is ¥2.22. Overall, Harbin Pharmaceutical Group Co has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Harbin Pharmaceutical Group Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Harbin Pharmaceutical Group Co's Cyclically Adjusted Book per Share of ¥2.22 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Harbin Pharmaceutical Group Co and its competitors. Harbin Pharmaceutical Group Co's current Cyclically Adjusted Book per Share is ¥2.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harbin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Harbin Pharmaceutical Group Co (SHSE:600664) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.51, compared to a current price of ¥4.94 — trading 40.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥2.22. Harbin Pharmaceutical Group Co's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Harbin Pharmaceutical Group Co (SHSE:600664), the current Cyclically Adjusted Book per Share is ¥2.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harbin Pharmaceutical Group Co (SHSE:600664) Overvalued in 2026?

Based on GuruFocus' analysis, Harbin Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥4.94 is trading 40.7% above its estimated GF Value™ of ¥3.51. GuruFocus considers Harbin Pharmaceutical Group Co to be Significantly Overvalued.

Key valuation signals for SHSE:600664:

  • Cyclically Adjusted Book per Share: ¥2.22
  • GF Value™: ¥3.51 vs. price of ¥4.94 (40.7% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600664 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Harbin Pharmaceutical Group Co Business Description

Address Xi\'an Street West, People \'s Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018
Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.
66GF Score

Get the complete analysis for SHSE:600664

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.94
Price
¥3.51
GF Value